News

Bloating is a symptom that makes your belly temporarily swell, often due to flares from comorbidities. Learn how abdominal ...
Results reveal that weight loss has significant effects on cellular processes that are known to affect metabolic health and ...
Researchers have mapped human fat tissue at single-cell resolution, uncovering how obesity alters cellular stress, ...
Wave Life Sciences Ltd. (NASDAQ:WVE) ranks among the best CRISPR stocks to buy. On June 23, H.C. Wainwright maintained its ...
Rani Therapeutics Holdings Inc (NASDAQ:RANI) experienced an 18% jump in its stock price following news that the clinical-stage biotherapeutics company will present preclinical findings on its ...
This discovery not only unveils a novel mechanism by which BAT influences liver metabolism but also highlights miR-206-3p as ...
A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.
Panelists discuss how the rapid adoption of subcutaneous (SubQ) oncology therapies creates challenges around clinical autonomy, infusion center sustainability, patient experience, and reimbursement ...
Panelists discuss how switching from intravenous (IV) to subcutaneous (SubQ) therapies requires proactive management of reimbursement, authorizations, and clinical workflows—emphasizing early payer ...
High intramuscular fat, older age, and low serum albumin can predict mortality in patients starting dialysis, while albumin ...
A GLP-1/glucagon dual agonist conferred weight loss of up to 12.55% at 32 weeks for adults with overweight or obesity, ...